Aslab Science P.S.A.
Other research and experimental development on natural sciences and engineering
Overview
Aslab Science is a research and development center that specializes in innovative solutions for the pharmaceutical and novel foods industries. They offer professional consulting services, physicochemical analyses, synthesis of chemical substances, and in vitro and clinical research. Additionally, they provide custom active substances and engineering process services to support product development.
- Fabryczna 5, 05-077 Warszawa
Financials
Revenue history (in k)
From the notes
| Profit allocation | No decision | |
| R&D costs | $721,234 |
Filing timeliness
1 of 3 financial statements was filed late (for 2024, 63 days late). 1 of 3 audited by a statutory auditor.
- 202518/05/2026
- 202416/09/2025
- 202330/06/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Research consulting services
- Physicochemical analysis
- Peptide synthesis
- Biopolymer synthesis
- In vitro testing
- Clinical trials
- Custom active ingredients
- Drug formulation development
Clients and partners
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-09-11.
20 1600 1462 1722 1404 3000 0004
04 1600 1462 1722 1404 3000 0001
74 1600 1462 1722 1404 3000 0002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 11, 2026 | Aid for research and development projects: industrial research | $1.6M$1,599,055 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 11, 2026 | Aid for research and development projects: industrial research | $1.3M$1,343,463 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Mar 17, 2024 | Aid for research and development projects: industrial research | $134.8K$134,809 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Badawczo-Rozwojowe Novasome sp. z o.o. | $3,159,753.62 | novasome.pl | ||
| Ekotechlab Marek Klein S.K.A. | $1,707,829.93 | ekotechlab.pl | ||
| Laboratorium Analiz Chemicznych Spark-Lab sp. z o.o. | $1,622,064.93 | spark-lab.pl | ||
| Laboratorium Badawcze Sorbolab sp. z o.o. | $1,593,152.63 | sorbolab.pl | ||
| Pikralida sp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Bioresearch Group sp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Lymelab Pharma sp. k. | $696,422.30 | lymelabpharma.com | ||
| CTI Clinical Trial and Consulting Services Poland sp. z o.o. | $527,145.56 | ctifacts.com | ||
| MT Laboratories sp. z o.o. | $489,455.67 | mtlab.pl | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl |
FAQ
Last updated: 2026-05-18


